Table 7 Correlation between NLR and DFS, 5-year survival and OS by stage, after adjusting it by gender, age, location of the primary tumor, differentiation as well as presence of perineural, vascular, and lymphovascular invasion
From: Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients
| Â | DFS | 5-year survival | Overall Survival | ||||||
|---|---|---|---|---|---|---|---|---|---|
HR | 95% Confidence Interval | p value | HR | 95% Confidence Interval | p value | HR | 95% Confidence Interval | p value | |
Stage I | |||||||||
 NLR > 4.7 | 1.60 | 0.19–13.41 | 0.663 | 2.06 | 0.23–18.18 | 0.514 | 1.85 | 0.22–15.88 | 0.572 |
Stage II | |||||||||
 NLR > 4.7 | 2.85 | 1.21–6.73 | 0.017 | 4.06 | 1.66–9.93 | 0.002 | 4.07 | 1.67–9.91 | 0.002 |
Stage III | |||||||||
 NLR > 4.7 | 1.33 | 0.54–3.28 | 0.537 | 1.28 | 0.50–3.22 | 0.605 | 1.27 | 0.50–3.18 | 0.612 |